Molly Marshall, PA
Surgical · Wyoming, MINPI 1962436584
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $984 of the $1,605 with a category attached, or 61.3%. Organogenesis Inc. accounts for 81.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $897 and has fallen 86.9% since, to $118 in 2025.
Across 34 payments — averaging $47.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- KCI USA, Inc.$114
- Mimedx Group, Inc.$48
- Urgo Medical North America, LLC$30
- Integra Lifesciences Corporation$27
- Kerecis Limited$25
- plus $51 from 3 others
What the payments were for
- Travel & lodging$62139%
- Food & beverage$98461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 23 | $1,311 |
| KCI USA, Inc. | 2 | $114 |
| Mimedx Group, Inc. | 2 | $48 |
| Urgo Medical North America, LLC | 1 | $30 |
| Integra Lifesciences Corporation | 2 | $27 |
| Kerecis Limited | 1 | $25 |
| Bsn Medical Inc | 1 | $22 |
| Smith+Nephew | 1 | $16 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$552
- PURAPLY WOUND MATRIX$430
- NuShield$430
- NOVACHOR$430
- Affinity$430
- Puraply Antimicrobial$121
How this compares
$1,605 in reported general payments places this provider in the 80th percentile of 229 surgical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 14 | $346 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $156 |
| Doxycycline Hyclate | 26 | $85 |
Paid to pharmacies, not to this prescriber.
Other surgical in Wyoming
- Jessica HumphreyRedford Twp$225K
- Michael BaldwinDearborn$12K
- Leslie NicholsWoodhaven$11K
- Lisa BrownBay City$10K
- Lauren VandenbergThree Rivers$9K
- Sara FukuzawaRoyal Oak$5K
- Krista McCarverNovi$4K
- Deborah NobaniClinton Township$4K
- James ProkosPetoskey$4K
- Gary ErrigoSouthfield$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.